We are live on ! Find out more
SFU

Stonehage Fleming (UK) Portfolio holdings

AUM $220M
1-Year Est. Return 0.72%
This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+0.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$222M
AUM Growth
+$6.24M
Cap. Flow
+$7.63M
Cap. Flow %
3.44%
Top 10 Hldgs %
26.79%
Holding
215
New
22
Increased
26
Reduced
29
Closed
28

Top Buys

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$3.94M
2
GME icon
GameStop
GME
+$3.7M
3
CRL icon
Charles River Laboratories
CRL
+$2.32M
4
VMW
VMware, Inc
VMW
+$2.22M
5
ROK icon
Rockwell Automation
ROK
+$2.2M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.08M
2
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$3.26M
3
ALTR
Altera Corp
ALTR
+$2.52M
4
AMGN icon
Amgen
AMGN
+$2.26M
5
EPC icon
Edgewell Personal Care
EPC
+$2.22M

Sector Composition

Rank Sector Weight
1 Technology 19.69%
2 Consumer Discretionary 16.23%
3 Industrials 12.23%
4 Healthcare 9.98%
5 Materials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
176
AT&T
T
$159B
$36K 0.02%
1,324
– –
META icon
177
Meta Platforms (Facebook)
META
$1.42T
$35K 0.02%
410
– –
GOLD
178
DELISTED
Randgold Resources Ltd
GOLD
$33K 0.01%
503
– –
BSBR icon
179
Santander
BSBR
$42.5B
$27K 0.01%
5,220
– –
FSLR icon
180
First Solar
FSLR
$22.7B
$23K 0.01%
500
-600
-55% -$33.5K
TDF
181
Templeton Dragon Fund
TDF
$270M
$22K 0.01%
900
– –
XOM icon
182
ExxonMobil
XOM
$644B
$21K 0.01%
250
– –
NICE icon
183
Nice
NICE
$5.79B
$16K 0.01%
250
– –
AHL
184
DELISTED
ASPEN Insurance Holding Limited
AHL
$16K 0.01%
344
– –
CELG
185
DELISTED
Celgene Corp
CELG
$12K 0.01%
100
– –
CHA
186
DELISTED
China Telecom Corporation, LTD
CHA
$10K ﹤0.01%
170
– –
NFLX icon
187
Netflix
NFLX
$299B
$9K ﹤0.01%
7,000
– –
AMGN icon
188
Amgen
AMGN
$208B
– –
-14,149
Closed -$2.26M
AMZN icon
189
Amazon
AMZN
$2.92T
– –
-2,000
Closed -$43K
BUD icon
190
AB InBev
BUD
$170B
– –
-200
Closed -$24K
COP icon
191
ConocoPhillips
COP
$147B
– –
-16,850
Closed -$1.05M
COST icon
192
Costco
COST
$422B
– –
-3,930
Closed -$531K
CPRT icon
193
Copart
CPRT
$27B
– –
-6,400
Closed -$15K
CVS icon
194
CVS Health
CVS
$133B
– –
-500
Closed -$52K
EMR icon
195
Emerson Electric
EMR
$83.9B
– –
-32,700
Closed -$1.85M
EPC icon
196
Edgewell Personal Care
EPC
$1.25B
– –
-21,719
Closed -$2.22M
F icon
197
Ford
F
$58.5B
– –
-4,000
Closed -$60K
GILD icon
198
Gilead Sciences
GILD
$162B
– –
-8,310
Closed -$973K
LH icon
199
Labcorp
LH
$25B
– –
-19,322
Closed -$2.09M
LQD icon
200
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
– –
-26,750
Closed -$3.26M
5 6 7
8
9

Similar funds

AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
KM
KS Management New York $198M AUM 43.09% 1-Year Est. Return
TC
Taylor Cottrill New London, New Hampshire $194M AUM 1.15% 1-Year Est. Return
IA
Ibbotson Associates Chicago, Illinois $193M AUM 3.52% 1-Year Est. Return
BL
Bolton LP Greenwich, Connecticut $259M AUM 30.92% 1-Year Est. Return
QA
Quintium Advisors Knoxville, Tennessee $160M AUM 2.85% 1-Year Est. Return
THP
Telegraph Hill Partners San Francisco, California $159M AUM
SGH
Schonfeld Group Holdings Jericho, New York $158M AUM 12.17% 1-Year Est. Return

Stonehage Fleming (UK)'s Q2 2015 Portfolio in Review

As of Q2 2015, Stonehage Fleming (UK) held 215 positions worth $222M, up 2.9% from $216M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Stonehage Fleming (UK) deployed $7.63M of net new capital in Q2 2015, opening 22 new positions and adding to 26 existing holdings. Its largest new stake was Ingredion: 49,100 shares worth $3.92M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Pfizer, an estimated $4.08M trimmed.

  • Stonehage Fleming (UK)'s largest Q2 2015 buy was Ingredion: 49,100 shares worth $3.92M.
  • Stonehage Fleming (UK) added most to H&R Block in Q2 2015, an estimated $1.81M increase.
  • Stonehage Fleming (UK)'s biggest Q2 2015 reduction was Pfizer, cutting an estimated $4.08M.
  • Stonehage Fleming (UK) fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2015, selling an estimated $3.26M.
  • Stonehage Fleming (UK)'s ten largest holdings make up 27% of its $222M portfolio in Q2 2015.
  • Stonehage Fleming (UK) opened 22 new positions and closed 28 in Q2 2015.
  • Stonehage Fleming (UK)'s portfolio value rose 2.9% quarter-over-quarter to $222M.

Based on Stonehage Fleming (UK)'s 13F filing for Q2 2015, filed 11 Oct 2019.